Cargando…
Axillary adenopathy following COVID-19 vaccination: A single institution case series
Axillary adenopathy is a potential side effect following COVID-19 vaccination. We report four cases of axillary adenopathy in the setting of recent COVID-19 vaccination (Moderna and Pfizer-BioNTech) at our institution. Our cases show unilateral axillary adenopathy, as well as adenopathy persisting f...
Autores principales: | Duke, Heather, Posch, Liana, Green, Lauren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166813/ https://www.ncbi.nlm.nih.gov/pubmed/34303188 http://dx.doi.org/10.1016/j.clinimag.2021.05.023 |
Ejemplares similares
-
Unilateral axillary adenopathy in the setting of COVID-19 vaccine: Follow-up
por: Mehta, Nishi, et al.
Publicado: (2021) -
Unilateral axillary Adenopathy in the setting of COVID-19 vaccine
por: Mehta, Nishi, et al.
Publicado: (2021) -
Axillary adenopathy detected on breast MRI following COVID-19 vaccination: outcomes and follow-up recommendations
por: Nguyen, Derek L., et al.
Publicado: (2023) -
Invited Commentary: Evolving Management of COVID-19
Vaccine–related Axillary Adenopathy
por: Weinstein, Susan
Publicado: (2022) -
Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination
por: Horvat, Joao V., et al.
Publicado: (2022)